Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.3.1643

Scoring System and Management Algorithm Assessing the Role of Survivin Expression in Predicting Progressivity of HPV Infections in Precancerous Cervical Lesions  

Indarti, Junita (Department of Obstetrics and Gynecology, Cipto Mangunkusumo National Referral Hospital)
Aziz, M. Farid (Department of Obstetrics and Gynecology, Cipto Mangunkusumo National Referral Hospital)
Suryawati, Bethy (Department of Anatomic Pathology, Faculty of Medicine, Padjajaran University)
Fernando, Darrell (Faculty of Medicine, University of Indonesia)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.3, 2013 , pp. 1643-1647 More about this Journal
Abstract
Background: To identify the risk factors and assess the role of survivin in predicting progessivity precancerous cervical lesions. Materials and Methods: This case-control study was conducted from October 2009 until May 2010. We obtained 74 samples, classified according to the degree of cervical intraepithelial neoplasia (CIN): 19 samples for CIN 1, 18 samples for CIN 2, 18 samples for CIN 3, and 19 samples as controls. Demographic profiles and risk factors assesment, histopathologic examination, HPV DNA tests, immunocytochemistry (ICC) and immunohistochemistry (IHC) staining for survivin expression were performed on all samples. Data was analyzed with bivariate and multivariate analysis. Results: Multivariate analysis revealed significant risk factors for developing precancerous cervical lesions are age <41 years, women with ${\geq}2$ sexual partners, course of education ${\geq}13$ years, use of oral contraceptives, positive high-risk HPV DNA, and high survivin expression by ICC or IHC staining. These factors were fit to a prediction model and we obtained a scoring system to predict the progressivity of CIN lesions. Conclusions: Determination of survivin expression by immunocytochemistry staining, along with other significant risk factors, can be used in a scoring system to predict the progressivity of CIN lesions. Application of this scoring system may be beneficial in determining the action of therapy towards the patient.
Keywords
Precancerous cervical lesions; cervical intraepithelial neoplasia; survivin; immunocytochemistry;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Almonte M, Ferreccio C, Gonzales M (2011). Risk factors for high-risk human papillomavirus infection and cofactors for high-grade cervical disease in Peru. Int J Gynecol Cancer, 21, 1654-63.   DOI   ScienceOn
2 American Cancer Society (2009). What Are the Risk Factors for Cervical Cancer? Available at http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-risk-factors. Accessed July 14, 2010.
3 Belinson S, Smith JS, Myers E, et al (2008). Descriptive evidence that risk profiles for cervical intraepithelial neoplasia 1, 2, and 3 are unique. Cancer Epidemiol Biomarkers Prev, 17, 2350-5.   DOI   ScienceOn
4 Barbosa LC, da Silva ID, Correa JC, Ribalta JC (2011). Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions. Int J Gynecol Cancer, 21, 15-21.   DOI   ScienceOn
5 Bibbo M, Klump WJ, DeCecco J, Kovatich AJ (2002). Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol, 46, 25-9.   DOI   ScienceOn
6 Boone JD, Erickson BK, Huh WK (2012). New insights to cervical cancer screening. J Gynecol Oncol, 23, 282-7.   DOI   ScienceOn
7 Borbely AA, Murvai M, Konya J et al (2006). Effects of human papillomavirus type 16 oncoproteins on survivin gene expression. J Gen Virol, 87, 287-94.   DOI   ScienceOn
8 Branca M, Giorgi C, Santini D, et al (2005). Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol, 124, 113-21.   DOI   ScienceOn
9 Branca M, Ciotti M, Giorgi C et al (2008). Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling. Int J Gynecol Pathol, 27, 265-73.
10 Castle PE, Cox JT, Schiffman M WC, Solomon D (2008). Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology. Obstet Gynecol, 112, 637-45.   DOI   ScienceOn
11 de Boer MA, Vet JN, Aziz MF et al (2006). Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. Int J Gynecol Cancer, 16, 1809-14.   DOI   ScienceOn
12 Engberts MK, Verbruggen BS, Boon ME, van Haaften M, Heintz AP (2007). Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis. Cancer, 111, 269-74.   DOI   ScienceOn
13 Gadducci A, Barsotti C, Cosio S, Domenici L, Riccardo GA (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecol Endocrinol, 27, 597-604.   DOI   ScienceOn
14 Gillet E, Meys JFA, Verstraelen H, et al (2012). Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and metaanalysis. PLoS One, 7, 45201.   DOI
15 Kim K, Kim JJ, Kim SM, No JH, Kim YB (2012). Prevalence and determinants of high-risk human papillomavirus infection in women with high socioeconomic status in Seoul, Republic of Korea. Asian Pac J Cancer Prev, 13, 269-73.   과학기술학회마을   DOI   ScienceOn
16 Hellberg D, Stendahl U (2005). The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer. Anticancer Res, 25, 3041-6.
17 Jensen KE, Schmiedel S, Norrild B et al (2013). Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer, 108, 234-9.   DOI   ScienceOn
18 Kim JW, Song SH, Jin CH, et al (2012). Factors affecting the clearance of high-risk human papillomavirus infection and the progression of cervical intraepithelial neoplasia. J Int Med Res, 40, 486-96.   DOI
19 Li F (2005). Role of survivin and its splice variants in tumorigenesis. Br J Cancer, 92, 212-6.
20 Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008). Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res, 14, 5000-5.   DOI   ScienceOn
21 Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maireang K (2011). Risk factors for high-grade cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance (ASC-US) Papanicolaou smears. Asian Pac J Cancer Prev, 12, 235-8.
22 Roeters AM, Boon ME, van Haaften M, et al (2010). Inflammatory events as detected in cervical smears and squamousintraepithelial lesions. Diagn Cytopathol, 38, 85-93.
23 Tan GC, Norlatiffah S, Sharifah NA et al (2010). Immunohistochemical study of p16 INK4A and survivin expressions in cervical squamous neoplasm. Indian J Pathol Microbiol, 53, 1-6.   DOI   ScienceOn
24 WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) (2010). Human Papillomavirus and Related Cancers in Indonesia. Summary Report 2010. Accessed 5 February 2013.